&#xa0;

[[[Written Evidence submitted by Dr Roland Salmon (CJD0002)]]]

[[[What do you consider to be the likely prevalence of subclinical ]]]

[[[vCJD]]]

[[[ infection in the UK population? What evidence is there to support this ]]]

[[[view?]]]&#xa0;

[[[How might th]]]

[[[is subclinical infection rate translate to future cases of ]]]

[[[vCJD]]]

[[[? What are the key uncertainties in the relationship between subclinical and clinical ]]]

[[[vCJD]]]

[[[?]]]&#xa0;&#xa0;

[[[What are the likely rou]]]

[[[tes of infection for ]]]

[[[vCJD]]]

[[[? How have the potential modes of transmission changed over time?]]]&#xa0;&#xa0;&#xa0;

[[[What procedures are currently in place to monitor, ]]]

[[[control and prevent further spread of ]]]

[[[vCJD]]]

[[[ across the UK population? What more could b]]]

[[[e done to reduce the risk pose]]]

[[[d ]]]

[[[by ]]]

[[[vCJD]]]

[[[?]]]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;

[[[Other considerations]]]&#xa0;&#xa0;

[[[References]]]&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;

[[[Declaration of interest]]]I am currently Board Member for Wales and Chair of the Welsh Food Advisory Committee for the Food Standards Agency and also a member of the Department of Health’s Advisory Committee on Dangerous Pathogens and of that committee’s Spongiform Encephalopathy Sub Group.  I am a member of the Conseil d’Administration (Management Advisory Board) of the Institut de Veille Sanitaire (French National Institute for Public Health Surveillance).&#xa0;November 2013&#xa0;